APA (7th ed.) Citation

K, P. F., M, G., LH, L., P, K., T, N., T, S., . . . RS, T. (2020). Utility of In Vitro Bioactivity as a Lower Bound Estimate of In Vivo Adverse Effect Levels and in Risk-Based Prioritization. Toxicological sciences : an official journal of the Society of Toxicology, 173(1), 202. https://doi.org/10.1093/toxsci/kfz201

Chicago Style (17th ed.) Citation

K, Paul Friedman, et al. "Utility of In Vitro Bioactivity as a Lower Bound Estimate of In Vivo Adverse Effect Levels and in Risk-Based Prioritization." Toxicological Sciences : An Official Journal of the Society of Toxicology 173, no. 1 (2020): 202. https://doi.org/10.1093/toxsci/kfz201.

MLA (9th ed.) Citation

K, Paul Friedman, et al. "Utility of In Vitro Bioactivity as a Lower Bound Estimate of In Vivo Adverse Effect Levels and in Risk-Based Prioritization." Toxicological Sciences : An Official Journal of the Society of Toxicology, vol. 173, no. 1, 2020, p. 202, https://doi.org/10.1093/toxsci/kfz201.